Table 1.
Description of study participants.
| Sociodemographic variables | Total (n = 481) | Total (n = 481) | |
|---|---|---|---|
| Age (years) | 40.9 ± 10.3 | Employed (working) | 16.2% |
| Gender (male) | 72.3% | Marital status (married) | 33.1% |
| Nationality (foreign) | 9.8% | Living with someone | 34.1% |
| Education (primary education) | 66.7% | Criminal record (prison) | 20.6% |
| Clinical variables related to comorbidities | |||
| Medical history | 60.7% | Axis II disorders | 44.7% |
| Psychiatric history | 62.2% | Cluster B | 28.7% |
| Axis I disorders | 43.7% | Other personality disorder | 9.3% |
| Anxiety disorder | 15.6% | Cluster C | 4.8% |
| Depressive disorder | 14.1% | Cluster A | 1.9% |
| Attention deficit hyperactivity disorder | 13.1% | ||
| Psychotic disorder | 8.5% | Prior psychiatric admissions | 15.6% |
| Bipolar disorder | 3.1% | ||
| Clinical variables related to consumption | |||
| Age at start of consumption | 17.8 ± 6.4 | Polysubstance users | 46.4% |
| Age at onset of substance use disorder | 24.1 ± 8.2 | Binge consumption prior to admission | 55.3% |
| Years of addiction | 16.6 ± 11.3 | Positive breath alcohol test on admission | 25.2% |
| Main Substance Use Disorder | Positive urinalysis on admission | 55.9% | |
| Alcohol | 42.4% | Prior detoxification admissions | 52% |
| Cocaine | 32.8% | ||
| Heroine | 12.9% | ||
| Cannabis | 7.1% | ||
| Benzodiazepines | 4.8% | ||
| Psychopharmacological and Psychological treatment | |||
| Antiepileptic | 69% | ADHD drugs | 4.7% |
| Antidepressant | 60.1% | Opioid agonists | 12.9% |
| Antipsychotic | 44.9% | Disulfiram/Namelfeno | 20.8% |
| Benzodiazepines | 6.9% | Group Psychotherapy | 81.1% |
| Insomnia symptoms | |||
| No insomnia symptoms during detoxification process | 33.5% | Type of insomnia | |
| Sleep-maintenance insomnia | 45.1% | ||
| Early morning awakening | 25.4% | ||
| Insomnia symptoms during detoxification process | 66.5% | Sleep-onset insomnia | 16.4% |
| Poor quality of nocturnal sleep | 12.3% | ||